Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Boron Biologicals Inc., Duke University deal

Boron received a license to Duke University technology relating

Read the full 97 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE